# Project Charter — p04-packageclinic-runtime-preflight

**Status:** Learner-approved project direction for Domain 03; Final PRD NOT CREATED. No current implementation started. Historical detailed scope draft remains recoverable from git history.

**Primary purpose:** build a useful product that challenges Node.js runtime fundamentals: event-loop responsiveness, asynchronous I/O, streams/backpressure, filesystem/resource ownership, process isolation, controlled cancellation and diagnostic evidence. These are learning challenges, NOT predetermined implementations.

# P04 — PackageClinic: Runtime Integration Preflight Desk — Product Requirements

**Domain:** D03 — Node.js Internals  
**Status:** approved_by_learner — product scope approved explicitly with five-project briefs batch on 2026-10-13  
**Concept:** learner-approved in five-item D03 catalog, 2026-10-13  
**project briefs approval:** explicit learner approval on 2026-10-13; technical implementation not started  
**Learning assessments / implementation:** deferred / not_started



## 1. Problem and motivation

A release can advertise compatible types or documented exports while actual Node entry points fail for the consumer's runtime due to package-scope interpretation, missing ESM extensions, export conditions or startup-time errors. **PackageClinic** helps an authorized package team **exercise a small catalog of trusted, explicitly approved integration scenarios** and record their reproducible outcomes. This is execution-backed preflight evidence, not a registry of asserted compatibility or a public code-execution platform.



## 2. Audience and actors

- **Package maintainer:** registers the release and a trusted compatibility case that they are authorized to test.
- **Consumer integrator:** selects supported consumer expectations, reviews test result and release comparison.
- **Authorized operator/reviewer:** approves what material and scenario may be executed and interprets failure evidence.
- **Workspace manager:** limits access to internal packages, reports and trusted test material.

Actors describe product responsibility and visibility, not a mandated identity implementation.



## 3. Goals and measurable outcomes

For an explicitly supported scenario and target Node runtime, a team can see whether **a real approved execution** passed or failed, with its environment, entry, observed error/outcome and bounded evidence. Results are reproducible enough for an engineer to investigate, and unsupported runtime combinations are never labeled compatible. No security isolation or cross-platform guarantee is assumed.

Evidence for these goals is the externally observable workflow and acceptance tests, **not** invented throughput, operational SLOs or deployed service results.



## 4. Product boundary: in / out / deferred

**In scope for V1:**
- Register a package/release reference and consumer entry/scenario with stable identifiers and declared provenance.
- Select from a deliberately **small, operator-approved catalog of runtime conditions and trusted scenarios**.
- Execute **only owner/operator-approved, trusted test material** within explicit safe-use conditions, or attach a clearly marked externally executed result as supplemental evidence.
- Record whether an individual scenario actually ran, passed, failed, could not run or produced an uncertain/incomplete outcome.
- Show human-readable failure class, relevant public entry/export/format expectation, runtime/environment and reproduction context.
- Compare observations for two eligible package releases without claiming universal future compatibility.
- Restrict scenario execution permissions and evidence viewing; preserve bounded history of observed results.

**Out of scope:**
- Public arbitrary-code-as-a-service, browser code playground, unrestricted third-party package execution or security-sandbox guarantee.
- Full npm registry/mirror, publish manager, automatic dependency upgrade or dependency vulnerability scanning.
- Full CI/CD platform, generalized load/stress testing or automatic production rollout.
- Assertion that running one small case proves security or all consumer use cases.

**Deferred until separately approved:**
- Accepting broader untrusted source packages (requires separate security/product scope approval, possibly a new product class).
- Large runtime/OS matrix, continuous scheduled checks and broad organization integrations.
- Generated migration patches, automated environment provisioning or comprehensive policy-as-code.

The product boundary is the approval target. Supporting technical mechanisms remain open and no project briefs sentence mandates a runtime topology or library.



## 12. Explicit non-goals

Not a general-purpose sandbox, remote code execution service, registry clone, full CI platform or security certification. **Untrusted code execution is explicitly out of V1**.

The handbook must not become an implementation repository, nor select its backend stack, database, deployment, communication protocol, workers, brokers, algorithms or vendor products.



## 13. Domain learning outcomes and why this project is valuable

**Possible D03 learning coverage:** D03-C02, C05, C11–C13, C14, C16–C18 (runtime identity, module resolution, process isolation challenges, failures, diagnostics).

**Distinctness and portfolio rationale:** Unlike D02 PackagePassport (cataloging declared compatibility), PackageClinic provides **bounded actual results of trusted execution cases**; unlike P03 NodeScope it validates package entry behavior, not historical incident metrics.

Learning coverage is a **planned educational challenge**, not a guarantee that implementation must use a specific technique, nor proof of an assessed skill.



## 14. Approval record

- **2026-10-13 — concept approval:** user approved all five ideas in the D03 candidate catalog.
- **2026-10-13 — project briefs author review:** authored as part of a five-project briefs batch using the approved concept, `templates/project-prd.md` and `docs/quality-gates.md`; status **in_review**.
- **2026-10-13 — project briefs approval:** learner explicitly approved all five project briefs as one batch; this product's scope and externally observable requirements are approved. Later detailed policies remain open for learner-led discovery.
- **Not started:** any learner study assessment, code, integration test, implementation repository work or technical ADR.
- **Later selected-project kickoff:** resolve necessary first-version product details using installed Matt Pocock skills and learner confirmation before technical design; require explicit approval for any changes to problem, audience, capabilities or in/out scope.

**Next gate:** reconcile global Coverage Matrix, domain indexes and both trackers, then close the D03 content-authoring gate following the five-project briefs batch approval. No D04 authoring or product implementation is started by this draft.


## Implementation kickoff gate

The independent-project Codex process must create and obtain explicit owner approval for `product-discovery.md`, then `final-prd.md`, then `module-plan.md`. Each approved module uses module-scoped technical discovery → to-spec → to-tickets → implementation → verification. Product scope cannot be expanded to force any Node.js mechanism.
